Methodology for small clinical trials;Méthodologie des essais cliniques de petits effectifs

Therapie

Volumn 59, Issue 3, 2004, Pages 281-286

  Vray, Muriel ^a   Girault, Danièle ^b   Hoog Labouret, Natalie ^c   Porcher, Raphaël ^d   Thalabard, Jean Christophe ^e  

^a INSTITUT PASTEUR   (France)

^b Laboratoires Takeda   (France)

^c AFSSAPS   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Level of proof; Small trials; Statistical methods

Indexed keywords

CLINICAL TRIAL; CONFERENCE PAPER; DECISION MAKING; EXPERIMENTAL DESIGN; METHODOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 7544246660     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2004054     Document Type: Conference Paper

References (20)

1. Evans CH, Ildstad ST. Small clinical trials: issues and challenges. Washington, DC: National Academy Press, 2003
2. GEREQ. Gestion électronique des données cliniques [online]. Available from URL: www.gereq.ca [Accessed 2004 July 1]
3. Matthews JNS. Small clinical trails: are they all bad? Stat Med 1995; 14: 115-26
4. Senn SJ. Cross-over trials in clinical research. Chichester: John Wiley & Sons, 1993
5. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome dedicated trial. STICLO Study Group. Lancet 2000; 356: 1638-42
6. Temple RJ. A Regulatory authority's opinion about surrogate endpoints. In: Nimmo WS, Tucker GT, editors. Clinical measurements in drug evaluation. Chichester: John Wiley & Sons Ltd, 1995
7. Armitage P. Sequential medical trials. 2nd ed. Oxford: Blackwell Scientific Publications, 1975
8. Whitehead J, Jones DR. The analysis of sequential trials. Biometrika 1979; 66: 105-13
9. Whitehead J. The design and analysis of sequential Trials. 2nd ed. Chichester: Ellis Horwood, 1992
10. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-56
11. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659-63
12. Posch M, Bauer P, Brannath W. Issues in designing flexible trials. Stat Med 2003; 22: 953-69
13. Jennison C, Turnbull BW. Mid-course sample size modification in clinical trials based on the observed treatment effect. Stat Med 2003; 22: 971-93
14. Rosenberger WF, Lachin JM. Randomization in clinical trials. New York: John Wiley & Sons, 2002
15. Zelen M. Play the winner and the controlled clinical trial. J Am Stat Assoc 1969; 64: 131-46
16. Wei LJ, Durham SD. The randomized play-the-winner rule in medical trials. J Am Stat Assoc 1978; 73: 840-3
17. Rosenberger WF. Randomized play-the-winner clinical trials: review and recommendations. Control Clin Trials 1999; 20: 328-42
18. Guyatt GH, Sackett D, Adachi J, et al. A clinicians' guide for conducting clinical trials in individual patients. CMAJ 1988; 139: 497-503
19. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in clinical trials. J Chronic Dis 1967; 20: 637-48
20. Vray M. Pragmatic and explanatory trials: ask and answer different questions. Appl Clin Trials 1999; 8: 42-50